Bradmer Pharmaceuticals Inc.: Director Resignation

Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.

Get Started

Bradmer Pharmaceuticals Inc. (the "Corporation") (TSX VENTURE:BMR.H) announced
today that Perry N. Dellelce has resigned as a director of the Corporation. He
will continue to act as a consultant to the Corporation. The Corporation thanks
Mr. Dellelce for his commitment and significant past contribution to the
Corporation.


NEITHER THE TSX VENTURE EXCHANGE NOR ITS REGULATION PROVIDER (AS THAT TERM IS
DEFINED IN THE POLICIES OF THE TSX VENTURE EXCHANGE) ACCEPTS RESPONSIBILITY FOR
THE ADEQUACY OR ACCURACY OF THIS RELEASE.


FOR FURTHER INFORMATION PLEASE CONTACT: 
Bradmer Pharmaceuticals Inc.
Paul Van Damme
Chief Financial Officer
416.847.6905

Bradmer Pharmaceuticals (TSXV:BMR.H)
Historical Stock Chart
From May 2024 to Jun 2024